Klaria Pharma Holding AB (publ.)

Klaria Pharma Holding AB (publ.)verified

KLAR.ST

Price:

$0.54

Market Cap:

$166.11M

Klaria Pharma Holding AB (publ.) operates as a pharmaceutical company in Sweden and internationally. It offers Sumatriptan for the treatment of migraine; and Midazolam for acute epilepsy. The company's clinical phase products include Epinephrine/Adrenaline for the treatment of acute allergic reaction; Naloxone for opioid overdose; and Ketamine for acute pain and depression. It also focuses on the commercialization of cannabis/cannabinoids, including THC and CBD for medical and recreational applications. The company was founded in 2014 and is based in Uppsala, Sweden.

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2015-10-21

Stock Exchange

STO

Ticker

KLAR.ST

The PE Ratio as of December 2025 (TTM) for Klaria Pharma Holding AB (publ.) (KLAR.ST) is -1.86

According to Klaria Pharma Holding AB (publ.)’s latest financial reports and current stock price. The company's current PE Ratio is -1.86. This represents a change of -77.51% compared to the average of -8.27 of the last 4 quarters.

Klaria Pharma Holding AB (publ.) (KLAR.ST) Historical PE Ratio (quarterly & annually)

How has KLAR.ST PE Ratio performed in the past?

The mean historical PE Ratio of Klaria Pharma Holding AB (publ.) over the last ten years is -8.88. The current -1.86 PE Ratio has changed 1.99% with respect to the historical average. Over the past ten years (40 quarters), KLAR.ST's PE Ratio was at its highest in in the March 2021 quarter at 6.83. The PE Ratio was at its lowest in in the September 2017 quarter at -59.77.

Quarterly (TTM)
Annual

Average

-8.88

Median

-6.19

Minimum

-23.44

Maximum

-0.87

Klaria Pharma Holding AB (publ.) (KLAR.ST) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Klaria Pharma Holding AB (publ.) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 21.43%

Maximum Annual PE Ratio = -0.87

Minimum Annual Increase = -Infinity%

Minimum Annual PE Ratio = -23.44

Quarterly (TTM)
Annual
YearPE RatioChange
2024-0.87-31.87%
2023-1.2821.43%
2022-1.06-83.40%
2021-6.3714.34%
2020-5.57-7.37%
2019-6.01-45.54%
2018-11.04-23.70%
2017-14.47-22.59%
2016-18.69-20.26%
2015-23.44-Infinity%

Klaria Pharma Holding AB (publ.) (KLAR.ST) Average PE Ratio

How has KLAR.ST PE Ratio performed in the past?

The current PE Ratio of Klaria Pharma Holding AB (publ.) (KLAR.ST) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.07

5-year avg

-3.03

10-year avg

-8.88

Klaria Pharma Holding AB (publ.) (KLAR.ST) PE Ratio vs. Peers

How is KLAR.ST’s PE Ratio compared to its peers?

Klaria Pharma Holding AB (publ.)’s PE Ratio is greater than AcuCort AB (-5.86), greater than Enorama Pharma AB (publ) (-2.42), less than Q-linea AB (publ) (-0.90), less than Vivesto AB (-0.18), greater than BrainCool AB (publ) (-3.24), greater than Alzinova AB (publ) (-7.44), greater than Integrum AB (publ) (-7.82), less than Xbrane Biopharma AB (publ) (1.93), greater than Isofol Medical AB (publ) (-3.57), less than SciBase Holding AB (publ) (-1.45),

Build a custom stock screener for Klaria Pharma Holding AB (publ.) (KLAR.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Klaria Pharma Holding AB (publ.) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Klaria Pharma Holding AB (publ.) (KLAR.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Klaria Pharma Holding AB (publ.) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Klaria Pharma Holding AB (publ.)'s PE Ratio?

How is the PE Ratio calculated for Klaria Pharma Holding AB (publ.) (KLAR.ST)?

What is the highest PE Ratio for Klaria Pharma Holding AB (publ.) (KLAR.ST)?

What is the 3-year average PE Ratio for Klaria Pharma Holding AB (publ.) (KLAR.ST)?

What is the 5-year average PE Ratio for Klaria Pharma Holding AB (publ.) (KLAR.ST)?

How does the current PE Ratio for Klaria Pharma Holding AB (publ.) (KLAR.ST) compare to its historical average?